Cover Image

The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis

Background: Percutaneous coronary intervention (PCI) is widely used in treatment of acute coronary syndrome (ACS) clinically. It is believed that Danhong injection (DHI) extracted from salviae miltiorrhizae and flos carthami combined with PCI could increase the therapeutic efficacy on ACS. We provid...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jun-Bo Zou (Author), Xiao-Fei Zhang (Author), Jing Wang (Author), Fang Wang (Author), Jiang-Xue Cheng (Author), Fang-Yan Yang (Author), Xiao Song (Author), Yu Wang (Author), Yu-Lin Liang (Author), Ya-Jun Shi (Author)
Format:	Book
Published:	Frontiers Media S.A., 2018-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Danhong Injection Price Trend and Its Utilization by Coronary Heart Disease Patients: Evidence From Hospital Records in China
by: Liming Liu, et al.
Published: (2022)

Danhong Injection Protects Hemorrhagic Brain by Increasing Peroxiredoxin 1 in Aged Rats
by: Shang Wang, et al.
Published: (2020)

Effect of indobufen vs. aspirin on platelet accumulation in patients with stable coronary heart disease after percutaneous coronary intervention: An open-label crossover study
by: Qiu-Ping Shi, et al.
Published: (2022)

The Effect of Total Cholesterol Variability on Clinical Outcomes After Percutaneous Coronary Intervention
by: Yanting Liang, et al.
Published: (2022)

Factors contributing to exercise tolerance in patients with coronary artery disease undergoing percutaneous coronary intervention
by: Husheng Li, et al.
Published: (2023)

Danhong Injection Attenuates Cerebral Ischemia-Reperfusion Injury in Rats Through the Suppression of the Neuroinflammation
by: Haixia Du, et al.
Published: (2021)

Alteration of Amino Acid Profiling Influenced by the Active Ingredients of DanHong Injection After Prescription Optimization
by: Guo Z, et al.
Published: (2019)

Danhong Injection for the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis
by: YiZhuo Li, et al.
Published: (2020)

Association between late sleeping and major adverse cardiovascular events in patients with percutaneous coronary intervention
by: Xiao-Qing Lian, et al.
Published: (2024)

Effects of sodium tanshinone IIA sulfonate injection on inflammatory factors and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials
by: Zunqi Kan, et al.
Published: (2023)

Clinical Outcomes of Patients with Coronary Artery Diseases and Moderate Left Ventricular Dysfunction: Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery
by: Wang S, et al.
Published: (2021)

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
by: M. Yu. Gilyarov, et al.
Published: (2021)

Effects of multidisciplinary exercise management on patients after percutaneous coronary intervention: A randomized controlled study
by: Ya-Jie Shi, et al.
Published: (2022)

A meta‐analysis and cost‐minimization analysis of bivalirudin versus heparin in high‐risk patients for percutaneous coronary intervention
by: Ke‐Xin Sun, et al.
Published: (2021)

Residual Dyslipidemia Leads to Unfavorable Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention
by: Bin Que, et al.
Published: (2016)

Influencing factors of care dependence in patients with coronary heart disease after percutaneous coronary intervention-A cross‐sectional study
by: Juan Guo, et al.
Published: (2023)

Retrospective analysis of exercise capacity in patients with coronary artery disease after percutaneous coronary intervention or coronary artery bypass graft
by: Ying Li, et al.
Published: (2021)

Danhong Injection Combined With t-PA Improves Thrombolytic Therapy in Focal Embolic Stroke
by: Min Li, et al.
Published: (2018)

Physical activity levels and predictors in patients following percutaneous coronary intervention: a cross-sectional study
by: Feng Xiao-Lin, et al.
Published: (2023)

The Management of Heavy Menstrual Bleeding After Percutaneous Coronary Intervention in a Woman of Reproductive Age
by: Zhi-Chun Gu, et al.
Published: (2019)

Predictors and Outcomes of Secondary Prevention Medication in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
by: Tianyu Li, et al.
Published: (2021)

Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
by: Jialun Han, et al.
Published: (2023)

Prior percutaneous coronary intervention and outcomes in patients after coronary artery bypass grafting: a meta-analysis of 308,284 patients
by: Hongliang Zhang, et al.
Published: (2022)

Comprehensive effect of Naoxintong capsule combined with Western medicine on coronary heart disease after percutaneous coronary intervention: a meta-analysis
by: Liyuan Yu, et al.
Published: (2024)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
by: Son V Pham, et al.
Published: (2010)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019)

Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention in Hutchinson-Gilford Progeria
by: Luciano De Simone, et al.
Published: (2023)

The quality of life of patients with coronary artery disease after percutaneous coronary interventions
by: Karolina Hajduga, et al.
Published: (2023)

Left main coronary disease percutaneous coronary intervention: The quest to reconcile the inconsistencies
by: Juan F. Iglesias, et al.
Published: (2021)

Musk Tongxin Dripping Pills for treating Ticagrelor in Patients After Percutaneous Coronary Intervention: Echocardiography Combined with Untargeted Metabolomics
by: Lyu Nan, et al.
Published: (2021)

Perceptions of patients undergoing percutaneous coronary intervention on pre‐operative education in China: A qualitative study
by: Qiqi Zhuo, et al.
Published: (2021)

A late complication of coronary artery perforation during primary percutaneous coronary intervention: Coronary arteriovenous fistula
by: Kayıhan Karaman, et al.
Published: (2017)

A Case of Balloon Rupture Cause Serious Complication during Percutaneous Coronary Intervention
by: Jianan Li, et al.
Published: (2016)

Impact of Thrombocytopenia on In-Hospital Outcome in Patients Undergoing Percutaneous Coronary Intervention
by: Zhongxiu Chen, et al.
Published: (2021)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015)

Editorial: Primary percutaneous coronary intervention in octogenarians
by: Ertan Ökmen
Published: (2013)

Effectiveness of transradial access in percutaneous coronary interventionism.
by: Javier Almeida Gómez, et al.
Published: (2011)

PRASUGREL FOR THE TREATMENT OF ACUTE CORONARY SYNDROMES AND PERCUTANEOUS CORONARY INTERVENTION: STATUS UPDATE ON THE PROBLEM
by: O. O. Shakhmatova, et al.
Published: (2018)